Sox4 cooperates with Evi1 in AKXD-23 myeloid tumors via transactivation of proviral LTR

Blood

Volumn 107, Issue 2, 2006, Pages 733-741

  Boyd, Kathryn E ^b   Xiao, Ying Yi ^b   Fan, Kai ^b   Poholek, Amanda ^b   Copeland, Neal G ^b   Jenkins, Nancy A ^b   Perkins, Archibald S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ECOTROPIC VIRAL INTEGRATION SITE 1 PROTEIN; HIGH MOBILITY GROUP B PROTEIN; MESSENGER RNA; PROTEIN DERIVATIVE; RETROVIRUS VECTOR; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL MATURATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; GENE INSERTION; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC CODE; GENETIC TRANSFECTION; GRANULOCYTE; LEUKEMIA CELL; LONG TERMINAL REPEAT; MEDICAL DOCUMENTATION; MOUSE; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RNA ANALYSIS; TRANSACTIVATION; TRANSCRIPTION REGULATION; TUMOR DIFFERENTIATION; UPREGULATION; VIRAL GENE DELIVERY SYSTEM; VIRUS ACTIVATION; VIRUS TRANSCRIPTION;

EID: 30444437492     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2003-05-1626     Document Type: Article

References (58)

1. Adams J, Cory S. Oncogene cooperation in leukaemogenesis. Cancer Surv. 1992;15:119-141.
2. Mucenski ML, Taylor BA, Ihle JN, Hartley JW, Morse HC III, Jenkins NA, Copeland NG. Identification of a common ecotropic viral integration site, Evi-1, in the DNA of AKXD murine myeloid tumors. Mol Cell Biol. 1988;8:301-308.
3. Mucenski ML, Taylor BA, Jenkins NA, Copeland NG. AKXD recombinant inbred strains: models for studying the molecular genetic basis of murine lymphomas. Mol Cell Biol. 1986;6:4236-4243.
4. Bergeron D, Poliquin L, Kozak C, Rassart E. Identification of a common viral integration region in Cas-Br-E murine leukemia virus-induced non-T-, non-B-cell lymphomas. J Virol. 1991;65:7-15.
5. Levy ER, Parganas E, Morishita K, et al. DNA rearrangements proximal to the EVI1 locus associated with the 3q21q26 syndrome. Blood. 1994; 83:1348-1354.
6. Morishita K, Parganas E, Willman CL, et al. Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26. Proc Natl Acad Sci U S A. 1992;89:3937-3941.
7. Suzukawa K, Parganas E, Gajjar A, et al. Identification of a breakpoint cluster region 3′ of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogenous leukemias with inv(3)(q21q26). Blood. 1994;84:2681-2688.
8. Perkins AS, Fishel R, Jenkins NA, Copeland NG. Evi-1, a murine zinc finger proto-oncogene, encodes a sequence-specific DNA-binding protein. Mol Cell Biol. 1991;11:2665-2674.
9. Delwel R, Funabiki T, Kreider B, Morishita K, Ihle J. Four of the seven zinc fingers of the Evi-1 myeloid transforming gene are required for sequence-specific binding to GA(C/T)AAGA(T/C)AAGATAA. Mol Cell Biol. 1993;13:4291-4300.
10. Matsugi T, Morishita K, Ihle JN. Identification, nuclear localization, and DNA-binding activity of the zinc finger protein encoded by the Evi-1 myeloid transforming gene. Mol Cell Biol. 1990;10:1259-1264.
11. Perkins A, Kim J. Zinc fingers 1-7 of EVI1 fail to bind to the GATA motif by itself but require the core site GACAAGATA for binding. J. Biol. Chem. 1996;271:1104-1110.
12. Turner J, Crossley M. Cloning and characterization of mCtBP2, a co-repressor that associates with basic Kruppel-like factor and other mammalian transcriptional regulators. EMBO J. 1998;17:5129-5140.
13. Bartholomew C, Kilbey A, Clark A, Walker M. The Evi-1 proto-oncogene encodes a transcriptional repressor activity associated with transformation. Oncogene. 1997;14:569-577.
14. Yuasa H, Oike Y, Iwama A, et al. Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression. EMBO J. 2005;24:1976-1987.
15. Yatsula B, Lin S, Read A, et al. Identification of binding sites of EVI1 in mammalian cells. J. Biol Chem. 2005;280:30712-30722.
16. Morishita K, Parganas E, Matsugi T, Ihle JN. Expression of the Evi-1 zinc finger gene in 32Dcl3 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor. Mol Cell Biol. 1992;12:183-189.
17. Kreider B, Orkin S, Ihle J. Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid transforming gene. Proc Natl Acad Sci U S A. 1993;90:6454-6458.
18. Kurokawa M, Ogawa S, Tanaka T, et al. The AML1/Evi-1 fusion protein in the t(3;21) translocation exhibits transforming activity on Rat1 fibroblasts with dependence on the Evi-1 sequence. Oncogene. 1995;11:833-840.
19. Kilbey A, Bartholomew C. Evi-1 ZF1 DNA binding activity and a second distinct transcriptional repressor region are both required for optimal transformation of Rat1 fibroblasts. Oncogene. 1998;16:2287-2291.
20. Palmer S, Brouillet J, Kilbey A, et al. Evi-1 transforming and repressor activities are mediated by CtBP co-repressor proteins. J. Biol. Chem. 2001;276:25834-25840.
21. Louz D, van den Broek M, Verbakel S, et al. Erythroid defects and increased retrovirally-induced tumor formation in Evi1 transgenic mice. Leukemia. 2000;14:1876-1884.
22. Buonamici S, Li D, Chi Y, et al. EVI1 induces myelodysplastic syndrome in mice. J Clin Invest. 2004;114:713-719.
23. Cuenco G, Ren R. Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1/MDS1/EVI1 with BCR/ABL in the induction of acute myelogenous leukemia in mice. Oncogene. 2004;23:569-579.
24. Li J, Shen H, Himmel KL, et al. Leukaemia disease genes: large-scale cloning and pathway predictions. Nat Genet. 1999;23:348-353.
25. European Bioinformatics Institute (EBI) and Wellcome Trust Sanger Institute (WTSI). Ensembl DNA database. http://www.ensembl.org/Mus_musculus/.
26. Holmes K, Palaszynski E, Frederickson T, Morse H, Ihle J. Correlation of cell-surface phenotype with the establishment of interleukin 3-dependent cell lines from wild-mouse murine leukemia virus-induced neoplasms. Proc Natl Acad Sci U S A. 1985;82:6687-6691.
27. Ihle J, Rein A, Mural R. Immunologic and virologic mechanisms in retrovirus-induced murine leukemogenesis. In: Klein G, ed. Advanced Oncology. Vol 4. New York, NY: Raven; 1984:95-137.
28. Greenberger J, Eckner R, Sakakeeny M, et al. Interleukin-3-dependent hematopoietic progenitor cell lines. Fed Proc. 1983;42:2762.
29. Khanna-Gupta A, Zibello T, Kolla S, Neufeld EJ, Berliner N. CCAAT displacement protein (CDP/cut) recognizes a silencer element in the lactoferrin gene promoter. Blood. 1997;90:2784-2795.
30. Tsai S, Bartelmez S, Sitnicka E, Collins S. Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid development. Genes Dev. 1994;8:2831-2841.
31. Pear WS, Miller JP, Xu L, et al. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood. 1998;92:3780-3792.
32. Kuhlbrodt K, Herbarth B, Sock E, Enderich J, Hermans-Borgmeyer I, Wegner M. Cooperative function of POU proteins and SOX proteins in glial cells. J Biol Chem. 1998;273:16050-16057.
33. Morgenstern J, Land H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucl Acids Res. 1990;18:3587-3596.
34. Sambrook J, Russell D. Molecular Cloning: A Laboratory Manual. 3rd ed. Woodbury, NY: Cold Spring Harbor Laboratory Press; 2000.
35. Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci U S A. 1984;81:1991-1995.
36. Graham FL, van der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973;52:456-467.
37. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1989.
38. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
39. Cepko C. Retrovirus infection of cells in vitro and in vivo. In: Ausubel FM, Brent R, Kingston RE, et al, eds. Current Protocols in Molecular Biology. Vol 1. New York, NY: Greene Publishing Associates and John Wiley and Sons; 1993:9.14.1-9.14.3.
40. Colicelli J, Goff S. Sequence and spacing requirements of a retrovirus integration site. J Mol Biol 1988;199:47-59.
41. Pear W, Scott M, Nolan G. Generation of high titre, helper-free retroviruses by transient transfection. In: Robbins P, ed. Methods in Molecular Medicine: Gene Therapy Protocols. Totowa, NJ: Humana Press; 1997:41-57.
42. Patel G, Kreider B, Rovera G, Reddy E. v-myb blocks granulocyte colony-stimulating-factor-induced myeloid differentiation but not proliferation. Mol Cell Biol. 1993;13:2269-2276.
43. O'Donnell L, Druhan L, Avalos B. Molecular characterization and expression analysis of leucine-rich alpha2-glycoprotein, a novel marker of granulocytic differentiation. J Leukoc Biol. 2002; 72:478-485.
44. Khanna-Gupta A, Lopingco M, Savinelli T, Zibello T, Berliner N, Perkins A. Retroviral insertional activation of the Evi1 oncogene does not prevent G-CSF-induced maturation of the murine pluripotent myeloid cell line, 32DCl3. Oncogene. 1996; 12:563-569.
45. Morishita K, Parker DS, Mucenski ML, Jenkins NA, Copeland NG, Ihle JN. Retroviral activation of a novel gene encoding a zinc finger protein in IL3-dependent myeloid leukemia cell lines. Cell. 1988;54:831-840.
46. Wegner M. From head to toes: the multiple facets of Sox proteins. Nucl Acids Res. 1999;27:1409-1420.
47. Geijsen N, Uings IJ, Pals C, et al. Cytokine-specific transcriptional regulation through an IL-5Ra interacting protein. Science. 2001;293:1136-1138.
48. Schilham M, Oosterwegel M, Moerer P, et al. Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4. Nature. 1996;380:711-714.
49. McGowan E, Clarke C. Effect of overexpression of progesterone receptor A on endogenous progestin-sensitive endpoints in breast cancer cells. Mol Endocrinol. 1999;13:1657-1671.
50. McCracken S, Kim C, Xu Y, Minden M, Miyamoto N. An alternative pathway for expression of p56lck from type I promoter transcripts in colon carcinoma. Oncogene. 1997;15:2929-2937.
51. Ahn S, Cho G, Jeong S, Rhim H, Choi J, Kim I. Identification of cDNAs for Sox-4, an HMG-Box protein, and a novel human homolog of yeast splicing factor SSF-1 differentially regulated during apoptosis induced by prostaglandin A2/delta 2-PGJ2 in Hep3B cells. Biochem Biophys Res Commun. 1999;260:216-221.
52. Lee C-J, Appleby V, Orme A, Chan W-I, Scotting P. Differential expression of SOX4 and SOX11 in medulloblastoma. J Neuro-Oncol. 2002;57:201-214.
53. Hansen GM, Skapura D, Justice MJ. Genetic profile of insertion mutations in mouse leukemias and lymphomas. Genome Res. 2000;10:237-243.
54. Du Y, Spence SE, Jenkins NA, Copeland NG. Cooperating cancer-gene identification via oncogenic-retrovirus-induced insertional mutagenesis. Blood. 2005;106:2495-2505.
55. Tchenio T, Casella J, Heidmann T. Members of the SRY family regulate the human LINE retrotransposons. Nucleic Acids Res. 2000;28:411-415.
56. Kustikova O, Fehse B, Modlich U, et al. Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science. 2005;308:1171-1174.
57. Calmels B, Ferguson C, Laukkanen M, et al. Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells. Blood. 2005;106:2530-2533.
58. Du Y, Jenkins N, Copeland N. Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells. Blood. Prepublished on August 18, 2005, as DOI 10.1182/blood-2005-03-1113.